There was no significant change in the expression of E-cadherin, however, the expression of N-cadherin, MMP-2, and MMP-9 decreased, further indicating that the downregulation of TBC1D1 affected the MMP family and thus weakened the aggressiveness of gliomas (Figure 5B). The gene discussed is TBC1D1; the disease is central nervous system cancer.